MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from offering,
net-Two Thousand Twenty...
$108,100K
Proceeds from offering,
net-At The Market...
$72,750K
Proceeds from shares
issued under equity...
$866K
Net cash provided by
financing activities
$180,566K
Effect of foreign
exchange rates on cash and...
$6K
Canceled cashflow
$1,150K
Net increase
(decrease) in cash and cash...
-$29,136K
Canceled cashflow
$180,572K
Non-cash interest
expense on liabilities...
$26,184K
Stock-based compensation
$12,649K
Loss from equity
method investment
-$8,727K
Impairment of right-of-use
assets and property,...
$4,441K
Depreciation and
amortization
$1,026K
Maturities of investments
$284,683K
Payments of offering
costs associated with...
$1,150K
Net cash used in
operating activities
-$208,511K
Canceled cashflow
$53,027K
Net cash provided by
(used in) investing...
-$1,197K
Canceled cashflow
$284,683K
Net loss
-$164,076K
Non-cash royalty revenue
related to the sales of...
$54,932K
Other assets
$15,449K
Operating leases, net
$15,157K
Accrued expenses
-$5,785K
Amortization of premiums
(discounts), net
-$5,514K
Accounts payable
-$625K
Purchases of investments
$285,012K
Benefit for income taxes
-$138K
Proceeds (payments)
relating to the sale of the...
-$697K
Purchases of property,
plant and equipment
$171K
Loss before equity
method investment
-$155,349K
Loss from equity
method investment
-$8,727K
Canceled cashflow
$138K
Loss before benefit
for income taxes and...
-$155,487K
Revenue
$55,232K
Interest income
$10,438K
Other income
(expense), net
$361K
Loss from operations
-$140,102K
Total non-operating
income (expense), net
-$15,385K
Canceled cashflow
$55,232K
Canceled cashflow
$10,799K
Total operating costs
and expenses
$195,334K
Non-cash interest
expense on liabilities...
$26,184K
Clinical development,
contract manufacturing...
$69,419K
Employee costs
$46,003K
Other operating costs
$44,727K
Other segment
expenses
$22,879K
Facilities costs
$12,306K
Rezpegaldesleukin
$51,531K
NKTRZero One Six Five
$9,569K
NKTRTwo Five Five
$6,486K
Discovery Research And
Other Programs
$1,833K
Back
Back
Cash Flow
source: myfinsight.com
NEKTAR THERAPEUTICS (NKTR)
NEKTAR THERAPEUTICS (NKTR)